- Home
- RGC vs ZTEK Comparison
RGC vs ZTEK Comparison
Compare RGC & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- ZTEK
- Stock Information
- Founded
- RGC 2014
- ZTEK 2008
- Country
- RGC Hong Kong
- ZTEK Canada
- Employees
- RGC N/A
- ZTEK N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- ZTEK Major Chemicals
- Sector
- RGC Health Care
- ZTEK Industrials
- Exchange
- RGC Nasdaq
- ZTEK Nasdaq
- Market Cap
- RGC 105.3M
- ZTEK 116.6M
- IPO Year
- RGC 2021
- ZTEK N/A
- Fundamental
- Price
- RGC $4.87
- ZTEK $1.03
- Analyst Decision
- RGC
- ZTEK
- Analyst Count
- RGC 0
- ZTEK 0
- Target Price
- RGC N/A
- ZTEK N/A
- AVG Volume (30 Days)
- RGC 51.3K
- ZTEK 42.0K
- Earning Date
- RGC 12-20-2024
- ZTEK 02-11-2025
- Dividend Yield
- RGC N/A
- ZTEK N/A
- EPS Growth
- RGC N/A
- ZTEK N/A
- EPS
- RGC N/A
- ZTEK N/A
- Revenue
- RGC N/A
- ZTEK $29,132.00
- Revenue This Year
- RGC N/A
- ZTEK N/A
- Revenue Next Year
- RGC N/A
- ZTEK N/A
- P/E Ratio
- RGC N/A
- ZTEK N/A
- Revenue Growth
- RGC N/A
- ZTEK 8.15
- 52 Week Low
- RGC $3.03
- ZTEK $0.50
- 52 Week High
- RGC $32.44
- ZTEK $1.59
- Technical
- Relative Strength Index (RSI)
- RGC 36.17
- ZTEK 47.23
- Support Level
- RGC $5.41
- ZTEK $1.05
- Resistance Level
- RGC $6.10
- ZTEK $1.16
- Average True Range (ATR)
- RGC 0.42
- ZTEK 0.09
- MACD
- RGC -0.10
- ZTEK -0.02
- Stochastic Oscillator
- RGC 1.14
- ZTEK 10.71
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.